Liver transplantation.

PubWeight™: 0.93‹?›

🔗 View Article (PMC 2852711)

Published in Gut Liver on September 30, 2009

Authors

Deok-Bog Moon1, Sung-Gyu Lee

Author Affiliations

1: Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Articles cited by this

(truncated to the top 100)

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med (1996) 22.46

A model to predict survival in patients with end-stage liver disease. Hepatology (2001) 18.06

Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med (2003) 8.47

Early indicators of prognosis in fulminant hepatic failure. Gastroenterology (1989) 7.43

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology (2001) 6.19

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology (1997) 5.53

The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology (2002) 4.98

Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12

Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health (2000) 3.82

Acute liver failure. N Engl J Med (1993) 3.81

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Consensus statement on the live organ donor. JAMA (2000) 3.29

De novo malignant tumors in organ transplant recipients. Transplant Proc (1971) 3.03

Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg (2000) 2.91

AASLD practice guidelines: Evaluation of the patient for liver transplantation. Hepatology (2005) 2.90

Right-liver living donor transplantation for decompensated end-stage liver disease. Liver Transpl (2002) 2.86

Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology (2007) 2.72

Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg (2005) 2.64

Lessons learned from 1,000 living donor liver transplantations in a single center: how to make living donations safe. Liver Transpl (2006) 2.58

A report of the Vancouver Forum on the care of the live organ donor: lung, liver, pancreas, and intestine data and medical guidelines. Transplantation (2006) 2.55

National Institutes of Health Consensus Development Conference Statement: liver transplantation--June 20-23, 1983. Hepatology (1984) 2.50

The utility of marginal donors in liver transplantation. Liver Transpl (2003) 2.49

Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann Surg (1997) 2.44

Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl (2004) 2.31

Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center. Liver Transpl (2008) 2.22

Liver transplantation for hepatocellular carcinoma. Gastroenterology (2005) 2.15

Laparoscopic living donor hepatectomy for liver transplantation in children. Lancet (2002) 2.15

Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease. Liver Transpl (2006) 2.02

Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl (2002) 2.00

Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl (2004) 1.88

Safety of donors in live donor liver transplantation using right lobe grafts. Arch Surg (2000) 1.82

Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study. Liver Transpl (2007) 1.68

Salvage living donor liver transplantation after prior liver resection for hepatocellular carcinoma. Liver Transpl (2007) 1.59

ABO-mismatch adult living donor liver transplantation using antigen-specific immunoadsorption and quadruple immunosuppression without splenectomy. Liver Transpl (2006) 1.57

Evaluation of living liver donors with an all-inclusive 3D multi-detector row CT protocol. Radiology (2006) 1.55

Congestion of right liver graft in living donor liver transplantation. Transplantation (2001) 1.51

Living-donor liver transplantation with monosegments. Transplantation (2003) 1.45

Organ donors with primary central nervous system tumor. Transplantation (2000) 1.43

Liver transplantation and hepatitis C virus: systematic review of antiviral therapy. Transplantation (2005) 1.42

The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation. Liver Transpl (2004) 1.41

Safety and necessity of including the middle hepatic vein in the right lobe graft in adult-to-adult live donor liver transplantation. Ann Surg (2003) 1.32

Cyclosporin versus tacrolimus for liver transplanted patients. Cochrane Database Syst Rev (2006) 1.29

Outcome of liver transplantation for hepatitis B in the United States. Liver Transpl (2004) 1.29

Lessons learned from one hundred right lobe living donor liver transplants. Ann Surg (2004) 1.24

The introduction of microvascular surgery to hepatic artery reconstruction in living-donor liver transplantation--its surgical advantages compared with conventional procedures. Transplantation (1992) 1.20

Optimal utilization of donor grafts with extended criteria: a single-center experience in over 1000 liver transplants. Ann Surg (2006) 1.20

Small-for-size graft in living donor liver transplantation: how far should we go? Liver Transpl (2003) 1.19

Liver transplantation in the United States from 1987-1998: updated results from the Pitt-UNOS Liver Transplant Registry. Clin Transpl (1998) 1.17

Live donors in liver transplantation. Gastroenterology (2008) 1.17

Modified right liver graft from a living donor to prevent congestion. Transplantation (2002) 1.16

Sirolimus in liver transplantation. Transplant Proc (2003) 1.13

Waitlist mortality decreases with increased use of extended criteria donor liver grafts at adult liver transplant centers. Am J Transplant (2007) 1.11

Liver transplantation for alcoholic liver disease: current concepts and length of sobriety. Liver Transpl (2004) 1.10

Ten years of liver transplantation: an evolving understanding of late graft loss. Transplantation (1997) 1.10

Living-donor liver transplantation in the United States: identifying donors at risk for perioperative complications. Am J Transplant (2007) 1.10

Hepatitis C recurrence after liver transplantation: Viral and histologic response to full-dose PEG-interferon and ribavirin. Am J Transplant (2006) 1.09

Split-liver transplantation: a review. Am J Transplant (2003) 1.08

Adult-adult right hepatic lobe living donor liver transplantation for status 2a patients: too little, too late. Liver Transpl (2002) 1.08

Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus. Transplantation (2000) 1.06

An analysis of late deaths after liver transplantation. Transplantation (1996) 1.06

Long-term incidence, risk factors, and management of biliary complications after adult living donor liver transplantation. Liver Transpl (2006) 1.06

Functional venous anatomy for right-lobe grafting and techniques to optimize outflow. Liver Transpl (2001) 1.05

Toward 300 liver transplants a year. Surg Today (2009) 1.05

Vein reconstruction in modified right liver graft for living donor liver transplantation. Ann Surg (2003) 1.04

"All-in-one" imaging protocols for the evaluation of potential living liver donors: comparison of magnetic resonance imaging and multidetector computed tomography. Liver Transpl (2005) 1.03

Recurrence of autoimmune liver disease after liver transplantation: a systematic review. Liver Transpl (2006) 1.03

Experience after the evaluation of 700 potential donors for living donor liver transplantation in a single center. Liver Transpl (2004) 1.02

Duct-to-duct biliary reconstruction in adult living-donor liver transplantation. Transplantation (2004) 1.01

Seventeen adult-to-adult living donor liver transplantations using dual grafts. Transplant Proc (2001) 1.00

Incidence and risk factors for cancer after liver transplantation. Crit Rev Oncol Hematol (2005) 0.99

Outcome analysis in adult-to-adult living donor liver transplantation using the left lobe. Liver Transpl (2003) 0.99

Live donor liver transplantation. Liver Transpl (2006) 0.99

Hepatitis B and hepatitis C viruses in liver transplantation. Transplantation (2004) 0.99

Liver and intestine transplantation in the United States, 1995-2004. Am J Transplant (2006) 0.99

Recurrence of diseases following orthotopic liver transplantation. Am J Gastroenterol (2006) 0.98

Reconstruction of middle hepatic vein of a living-donor right lobe liver graft with recipient left portal vein. Transplantation (2001) 0.98

Live donor liver transplantation in adults. Transplantation (2006) 0.98

Long-term management of the liver transplant patient: diabetes, hyperlipidemia, and obesity. Liver Transpl (2001) 0.94

Consensus conference: Indications for Liver Transplantation, January 19 and 20, 2005, Lyon-Palais Des Congrès: text of recommendations (long version). Liver Transpl (2006) 0.94

Transplant tumor registry: donors with central nervous system tumors1. Transplantation (2002) 0.93

Adult-to-adult living donor liver transplantation at the Asan Medical Center, Korea. Asian J Surg (2002) 0.93

Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years. Liver Transpl (2001) 0.93

Transplantation for hepatocellular carcinoma: The Milan criteria and beyond. Liver Transpl (2006) 0.92

Real-time monitoring of acute liver-allograft rejection using the Banff schema. Transplantation (2002) 0.91

Anterior segment congestion of a right liver lobe graft in living-donor liver transplantation and strategy to prevent congestion. J Hepatobiliary Pancreat Surg (2003) 0.91

Living-donor liver transplantation with renoportal anastomosis for patients with large spontaneous splenorenal shunts. Transplantation (2005) 0.90

An adult-to-adult living donor liver transplant using dual left lobe grafts. Surgery (2001) 0.90

Current indications and contraindications for liver transplantation. Clin Liver Dis (2007) 0.90

Living donor liver transplantation: present status and recent advances. Br Med Bull (2006) 0.89

Combination of extended donor criteria and changes in the Model for End-Stage Liver Disease score predict patient survival and primary dysfunction in liver transplantation: a retrospective analysis. Transplantation (2007) 0.89

Hepatic venoplasty in right lobe live donor liver transplantation. Liver Transpl (2003) 0.88

Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients. Clin Transplant (2006) 0.88

Successful ABO-incompatible pediatric liver transplantation utilizing standard immunosuppression with selective postoperative plasmapheresis. Liver Transpl (2006) 0.87

Extended-donor criteria liver allografts. Semin Liver Dis (2006) 0.87

Adult-to-adult living donor liver transplantation at the Asan Medical Center. Yonsei Med J (2004) 0.87

Review article: medical management of the liver transplant recipient - a primer for non-transplant doctors. Aliment Pharmacol Ther (2007) 0.87

Doppler assessment after right hepatectomy confirms the need to fix the remnant left liver in the anatomical position. Br J Surg (2005) 0.86

Techniques of reconstruction of hepatic veins in living-donor liver transplantation, especially for right hepatic vein and major short hepatic veins of right-lobe graft. J Hepatobiliary Pancreat Surg (2006) 0.86

Current trends in live liver donation. Transpl Int (2007) 0.86

Prevention of hepatitis B recurrence after living donor liver transplantation: primary high-dose hepatitis B immunoglobulin monotherapy and rescue antiviral therapy. Liver Transpl (2008) 0.86

Articles by these authors

(truncated to the top 100)

Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology (2006) 3.02

Lessons learned from 1,000 living donor liver transplantations in a single center: how to make living donations safe. Liver Transpl (2006) 2.58

Living donor liver transplantation: the Asian perspective. Transplantation (2014) 2.13

Reappraisal of percutaneous transhepatic biliary drainage tract recurrence after resection of perihilar bile duct cancer. World J Surg (2012) 1.73

Restoration of portal flow using a pericholedochal varix in adult living donor liver transplantation for patients with total portosplenomesenteric thrombosis. Liver Transpl (2014) 1.66

Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J Hepatol (2010) 1.61

Salvage living donor liver transplantation after prior liver resection for hepatocellular carcinoma. Liver Transpl (2007) 1.59

Donor selection for procurement of right posterior segment graft in living donor liver transplantation. Liver Transpl (2004) 1.56

Hepatic arterial stenosis assessed with doppler US after liver transplantation: frequent false-positive diagnoses with tardus parvus waveform and value of adding optimal peak systolic velocity cutoff. Radiology (2011) 1.55

Characteristics and management of splenic artery aneurysms in adult living donor liver transplant recipients. Liver Transpl (2009) 1.52

Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol (2008) 1.50

Exchange living donor liver transplantation to overcome ABO incompatibility in adult patients. Liver Transpl (2010) 1.46

Improved outcomes in liver transplantation in children with acute liver failure. J Pediatr Gastroenterol Nutr (2014) 1.45

Clinical value of APACHE scores in patients who require intensive care before liver transplantation. Hepatogastroenterology (2009) 1.45

The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation. Liver Transpl (2004) 1.41

[Clinical outcome after living donor liver transplantation in patients with hepatitis C virus-associated cirrhosis]. Korean J Hepatol (2007) 1.38

Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization only before major hepatectomy for patients with hepatocellular carcinoma. Ann Surg Oncol (2010) 1.35

Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index. Radiology (2007) 1.30

Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy. Ann Surg (2009) 1.29

Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations. Liver Transpl (2005) 1.27

Antioxidant effects of fermented red ginseng extracts in streptozotocin- induced diabetic rats. J Ginseng Res (2011) 1.25

Hepatectomy of living donors with a left-sided gallbladder and multiple combined anomalies for adult-to-adult living donor liver transplantation. Liver Transpl (2004) 1.21

Surgical experience of 204 cases of adult choledochal cyst disease over 14 years. World J Surg (2011) 1.18

Living-donor liver transplantation: 12 years of experience in Asia. Transplantation (2003) 1.16

Five-year follow-up of a hepatitis B virus-positive recipient of hepatitis B surface antigen-positive living donor liver graft. Liver Transpl (2006) 1.14

Oncological and surgical results of laparoscopic versus open liver resection for HCC less than 5 cm: case-matched analysis. Surg Endosc (2014) 1.14

Torsion of the gallbladder: report of a case. Yonsei Med J (2005) 1.13

The Impact of Tumor Size on Long-Term Survival Outcomes After Resection of Solitary Hepatocellular Carcinoma: Single-Institution Experience with 2558 Patients. J Gastrointest Surg (2015) 1.09

Surgical outcomes of hepatocellular carcinoma with bile duct tumor thrombus: a Korean multicenter study. World J Surg (2013) 1.08

Radiofrequency ablation for recurrent intrahepatic cholangiocarcinoma after curative resection. Eur J Radiol (2010) 1.07

Usability of ringed polytetrafluoroethylene grafts for middle hepatic vein reconstruction during living donor liver transplantation. Liver Transpl (2012) 1.07

Liver transplantation for HCC: its role: Eastern and Western perspectives. J Hepatobiliary Pancreat Sci (2009) 1.06

Long-term incidence, risk factors, and management of biliary complications after adult living donor liver transplantation. Liver Transpl (2006) 1.06

Sorafenib for recurrent hepatocellular carcinoma after liver transplantation. Jpn J Clin Oncol (2010) 1.05

Radical surgical resection for carcinoid tumors of the ampulla. J Gastrointest Surg (2007) 1.02

Prognostic Impact of Tumor Growth Type on 7th AJCC Staging System for Intrahepatic Cholangiocarcinoma: a Single-Center Experience of 659 Cases. J Gastrointest Surg (2015) 1.01

Prognostic nomograms for prediction of recurrence and survival after curative liver resection for hepatocellular carcinoma. Ann Surg (2015) 1.01

Cryopreserved iliac artery is indispensable interposition graft material for middle hepatic vein reconstruction of right liver grafts. Liver Transpl (2005) 1.00

Right lobe estimated blood-free weight for living donor liver transplantation: accuracy of automated blood-free CT volumetry--preliminary results. Radiology (2010) 0.98

Neurologic complications in adult living donor liver transplant recipients. Clin Transplant (2007) 0.98

Risk factors for central pontine and extrapontine myelinolysis following orthotopic liver transplantation. Eur Neurol (2009) 0.96

Is serum alpha-fetoprotein useful for predicting recurrence and mortality specific to hepatocellular carcinoma after hepatectomy? A test based on propensity scores and competing risks analysis. Ann Surg Oncol (2012) 0.96

Quantified Risk Assessment for Major Hepatectomy via the Indocyanine Green Clearance Rate and Liver Volumetry Combined with Standard Liver Volume. J Gastrointest Surg (2015) 0.96

Specificity of unenhanced CT for non-invasive diagnosis of hepatic steatosis: implications for the investigation of the natural history of incidental steatosis. Eur Radiol (2011) 0.95

Bile leak following living donor liver transplantation: clinical efficacy of percutaneous transhepatic treatment. Liver Transpl (2008) 0.95

Postoperative chemoradiotherapy for extrahepatic bile duct cancer. Int J Radiat Oncol Biol Phys (2010) 0.95

Quilt venoplasty using recipient saphenous vein graft for reconstruction of multiple short hepatic veins in right liver grafts. Liver Transpl (2005) 0.94

Primary malignant mesothelioma developed in liver. Hepatogastroenterology (2008) 0.94

Reconstruction of inferior right hepatic veins in living donor liver transplantation using right liver grafts. Liver Transpl (2012) 0.93

Liver transplantation and conventional surgery for advanced hepatocellular carcinoma. Transpl Int (2010) 0.93

Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection. Ann Surg Oncol (2009) 0.91

Prognostic impact of sarcomatous change of hepatocellular carcinoma in patients undergoing liver resection and liver transplantation. J Gastrointest Surg (2007) 0.91

Novel technique of implantation for reversed modified right lobe graft from a donor with situs inversus totalis: new challenge in adult living donor liver transplantation. Transpl Int (2013) 0.91

Hepatic venous congestion in living donor liver transplantation: preoperative quantitative prediction and follow-up using computed tomography. Liver Transpl (2004) 0.91

Pediatric liver transplantation outcomes in Korea. J Korean Med Sci (2013) 0.91

Long-term outcomes of pediatric living donor liver transplantation at a single institution. Pediatr Transplant (2010) 0.91

Long-term efficacy of stent placement for treating inferior vena cava stenosis following liver transplantation. Liver Transpl (2010) 0.90

Preoperative portal vein embolization and surgical resection in patients with hepatocellular carcinoma and small future liver remnant volume: comparison with transarterial chemoembolization. Ann Surg Oncol (2007) 0.90

Endovascular stent placement for interposed middle hepatic vein graft occlusion after living-donor liver transplantation using right-lobe graft. Liver Transpl (2006) 0.90

Contrast-enhanced computed tomography for the diagnosis of fatty liver: prospective study with same-day biopsy used as the reference standard. Eur Radiol (2009) 0.90

Safety of anti-hepatitis B core antibody-positive donors for living-donor liver transplantation. Transplantation (2003) 0.89

Cytomegalovirus infection-associated fulminant hepatitis in an immunocompetent adult requiring emergency living-donor liver transplantation: report of a case. Surg Today (2012) 0.89

Semiautomated spleen volumetry with diffusion-weighted MR imaging. Magn Reson Med (2011) 0.89

Management of subcapsular hematoma of the graft after living donor liver transplantation. Liver Transpl (2006) 0.88

Hepatic vein anatomy of the medial segment for living donor liver transplantation using extended right lobe graft. Liver Transpl (2005) 0.88

Treatment of recurrent bile duct stricture after primary reconstruction for laparoscopic cholecystectomy-induced injury. Surg Laparosc Endosc Percutan Tech (2008) 0.88

Delayed-onset isolated injury of the right posterior segment duct after laparoscopic cholecystectomy: a report of hepatic segmental atrophy induction. Surg Laparosc Endosc Percutan Tech (2007) 0.88

A clinical assessment of mycophenolate drug monitoring after liver transplantation. Clin Transplant (2010) 0.88

Interventional oncology: new options for interstitial treatments and intravascular approaches: right hepatic vein embolization after right portal vein embolization for inducing hypertrophy of the future liver remnant. J Hepatobiliary Pancreat Sci (2009) 0.87

Living donor liver transplantation. Curr Opin Organ Transplant (2014) 0.87

Resection of pulmonary metastases from hepatocellular carcinoma following liver transplantation. World J Surg (2012) 0.87

Adult-to-adult living donor liver transplantation at the Asan Medical Center. Yonsei Med J (2004) 0.87

Long-Term Outcome After Resection of Huge Hepatocellular Carcinoma ≥ 10 cm: Single-Institution Experience with 471 Patients. World J Surg (2015) 0.87

Half-life of serum alpha-fetoprotein: an early prognostic index of recurrence and survival after hepatic resection for hepatocellular carcinoma. Ann Surg (2013) 0.87

Modified liver hanging maneuver to facilitate left hepatectomy and caudate lobe resection for hilar bile duct cancer. J Gastrointest Surg (2007) 0.86

Prevention of hepatitis B recurrence after living donor liver transplantation: primary high-dose hepatitis B immunoglobulin monotherapy and rescue antiviral therapy. Liver Transpl (2008) 0.86

Experimental phasing using zinc anomalous scattering. Acta Crystallogr D Biol Crystallogr (2012) 0.86

Neutrophil gelatinase-associated lipocalin as an early biomarker of acute kidney injury in liver transplantation. Clin Transplant (2012) 0.86

Hepatogenic differentiation of mesenchymal stem cells in a rat model of thioacetamide-induced liver cirrhosis. Cell Biol Int (2012) 0.86

Hemodynamics-compliant reconstruction of the right hepatic vein for adult living donor liver transplantation with a right liver graft. Liver Transpl (2012) 0.86

Biopsy-proven nonsteatotic liver in adults: estimation of reference range for difference in attenuation between the liver and the spleen at nonenhanced CT. Radiology (2011) 0.86

Posttransplantation prophylaxis with primary high-dose hepatitis B immunoglobulin monotherapy and complementary preemptive antiviral add-on. Liver Transpl (2011) 0.85

Conjoined Unification Venoplasty for Double Portal Vein Branches of Right Liver Graft: 1-Year Experience at a High-Volume Living Donor Liver Transplantation Center. J Gastrointest Surg (2016) 0.85

Reappraisal of plasmapheresis as a supportive measure in a patient with hepatic failure after major hepatectomy. Case Rep Gastroenterol (2007) 0.85

Does portal vein resection with hepatectomy improve survival in locally advanced hilar cholangiocarcinoma? Hepatogastroenterology (2009) 0.85

Living donor liver transplantation. Curr Opin Organ Transplant (2010) 0.85

Liver transplantation for hepatocellular carcinoma: single nodule with Child-Pugh class A sized less than 3 cm. Dig Dis (2007) 0.85

Feasibility of semiautomated MR volumetry using gadoxetic acid-enhanced MRI at hepatobiliary phase for living liver donors. Magn Reson Med (2013) 0.84

Portal vein stenting for portal hypertension caused by local recurrence after pancreatoduodenectomy for periampullary cancer. J Gastrointest Surg (2007) 0.84

Pancreatic atrophy relative to external versus internal drainage of the pancreatic duct after pylorus-preserving pancreaticoduodenectomy. J Gastrointest Surg (2014) 0.84

Retroduodenal resection of ampullary carcinoid tumor in a patient with cavernous transformation of the portal vein. J Gastrointest Surg (2007) 0.83

Outflow vein reconstruction of extended right lobe graft using quilt venoplasty technique. Liver Transpl (2006) 0.83

Intraoperative biliary exploration through the left hepatic duct orifice during left hepatectomy in patients with left-sided hepatolithiasis. Langenbecks Arch Surg (2007) 0.83

Pancreatoduodenectomy for local intrapancreatic recurrence after bile duct resection of mid bile duct carcinoma. Hepatogastroenterology (2011) 0.83

Deep femoral artery aneurysm presenting as lower limb swelling: a case report. Yonsei Med J (2006) 0.83

Neuroendocrine tumors of the gallbladder: twelve cases in a single institution. Hepatogastroenterology (2011) 0.83

Is a stricter colonoscopy screening protocol necessary in liver transplant recipients? Comparison with an average-risk population. Dis Colon Rectum (2014) 0.83

Right anterior sector drainage in right-lobe live-donor liver transplantation. Transplantation (2003) 0.82

Side-to-end renoportal anastomosis using an externally stented polytetrafluoroethylene vascular graft for a patient with a phlebosclerotic portal vein and a large spontaneous splenorenal shunt. J Am Coll Surg (2011) 0.82

Transvenous variceal embolization during or after living-donor liver transplantation to improve portal venous flow. J Vasc Interv Radiol (2009) 0.82